Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2005 6
2006 7
2007 9
2008 8
2009 1
2010 3
2011 3
2012 3
2013 3
2014 5
2015 7
2016 10
2017 1
2019 6
2020 6
2021 4
2022 9
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review.
Laddha AP, Dzielak L, Lewis C, Xue R, Manautou JE. Laddha AP, et al. Among authors: manautou je. Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):167037. doi: 10.1016/j.bbadis.2024.167037. Epub 2024 Jan 31. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38295624 Review.
Nephrotoxicity of marketed antisense oligonucleotide drugs.
Wu H, Wahane A, Alhamadani F, Zhang K, Parikh R, Lee S, McCabe EM, Rasmussen TP, Bahal R, Zhong XB, Manautou JE. Wu H, et al. Among authors: manautou je. Curr Opin Toxicol. 2022 Dec;32:100373. doi: 10.1016/j.cotox.2022.100373. Epub 2022 Oct 21. Curr Opin Toxicol. 2022. PMID: 37193356 Free PMC article.
Rethinking Subthreshold Effects in Regulatory Chemical Risk Assessments.
Agathokleous E, Barceló D, Aschner M, Azevedo RA, Bhattacharya P, Costantini D, Cutler GC, De Marco A, Docea AO, Dórea JG, Duke SO, Efferth T, Fatta-Kassinos D, Fotopoulos V, Ginebreda A, Guedes RNC, Hayes AW, Iavicoli I, Kalantzi OI, Koike T, Kouretas D, Kumar M, Manautou JE, Moore MN, Paoletti E, Peñuelas J, Picó Y, Reiter RJ, Rezaee R, Rinklebe J, Rocha-Santos T, Sicard P, Sonne C, Teaf C, Tsatsakis A, Vardavas AI, Wang W, Zeng EY, Calabrese EJ. Agathokleous E, et al. Among authors: manautou je. Environ Sci Technol. 2022 Aug 16;56(16):11095-11099. doi: 10.1021/acs.est.2c02896. Epub 2022 Jul 25. Environ Sci Technol. 2022. PMID: 35878124 No abstract available.
Casimersen for the treatment of Duchenne muscular dystrophy.
Zakeri SE, Pradeep SP, Kasina V, Laddha AP, Manautou JE, Bahal R. Zakeri SE, et al. Among authors: manautou je. Trends Pharmacol Sci. 2022 Jul;43(7):607-608. doi: 10.1016/j.tips.2022.04.009. Epub 2022 May 14. Trends Pharmacol Sci. 2022. PMID: 35581038 No abstract available.
87 results